BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sugawara K, Yamashita H, Okumura Y, Yagi K, Yoshimura S, Kawasaki K, Tanabe A, Aikou S, Seto Y. Relationships among body composition, muscle strength, and sarcopenia in esophageal squamous cell carcinoma patients. Support Care Cancer 2020;28:2797-803. [DOI: 10.1007/s00520-019-05110-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Aichi M, Hasegawa S, Kurita Y, Shinoda S, Kato S, Mizushima T, Yokota NR, Miyagi E. Low skeletal muscle mass predicts poor prognosis for patients with stage III cervical cancer on concurrent chemoradiotherapy. Nutrition 2023;109:111966. [PMID: 36731243 DOI: 10.1016/j.nut.2022.111966] [Reference Citation Analysis]
2 Sugawara K, Fukuda T, Kishimoto Y, Oka D, Tanaka Y, Hara H, Yoshii T, Kawashima Y. The Impact of Pretreatment Esophageal Stenosis on Survival of Esophageal Cancer Patients. Ann Surg Oncol 2022. [DOI: 10.1245/s10434-022-12945-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Wu C, Jiang B, Wu Z, Dong L, Sun K, Wu M, Mei J. LOX and Its Methylation Impact Prognosis of Diseases and Correlate with TAM Infiltration in ESCA. Journal of Oncology 2022;2022:1-18. [DOI: 10.1155/2022/5111237] [Reference Citation Analysis]
4 Yu Y, Wu H, Qiu J, Ke D, Wu Y, Lin M, Liu T, Zheng Q, Zheng H, Yang J, Wang Z, Li H, Liu L, Yao Q, Li J, Cheng W, Chen X. A Nutrition-Related Factor-Based Risk Stratification for Exploring the Clinical Benefits in the Treatment of Patients With Locally Advanced Esophageal Squamous Cell Carcinoma Receiving Definitive Chemoradiotherapy: A Retrospective Cohort Study. Front Nutr 2022;9:896847. [PMID: 35990358 DOI: 10.3389/fnut.2022.896847] [Reference Citation Analysis]
5 Nishioka N, Naito T, Miyawaki T, Yabe M, Doshita K, Kodama H, Miyawaki E, Iida Y, Mamesaya N, Kobayashi H, Omori S, Ko R, Wakuda K, Ono A, Kenmotsu H, Murakami H, Takayama K, Takahashi T. Impact of losing adipose tissue on outcomes from PD-1/PD-L1 inhibitor monotherapy in non-small cell lung cancer. Thorac Cancer 2022. [PMID: 35420262 DOI: 10.1111/1759-7714.14421] [Reference Citation Analysis]
6 Ko N, Lee HH, Sohn MK, Kim DY, Shin YI, Oh GJ, Lee YS, Joo MC, Lee SY, Song MK, Han J, Ahn J, Lee YH, Chang WH, Choi SM, Lee SK, Lee J, Kim YH. Status of dysphagia after ischemic stroke: A Korean nationwide study. Arch Phys Med Rehabil 2021:S0003-9993(21)01313-7. [PMID: 34348122 DOI: 10.1016/j.apmr.2021.07.788] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
7 Onishi S, Tajika M, Tanaka T, Yamada K, Abe T, Higaki E, Hosoi T, Inaba Y, Muro K, Shimizu M, Niwa Y. Prognostic Impact of Sarcopenic Obesity after Neoadjuvant Chemotherapy Followed by Surgery in Elderly Patients with Esophageal Squamous Cell Carcinoma. J Clin Med 2020;9:E2974. [PMID: 32942595 DOI: 10.3390/jcm9092974] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
8 Sugawara K, Yamashita H, Okumura Y, Yagi K, Aikou S, Seto Y. Age-dependent survival impact of body mass index in patients with oesophageal squamous cell carcinoma. Eur J Surg Oncol 2020;46:1948-55. [PMID: 32654887 DOI: 10.1016/j.ejso.2020.05.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]